Abstract
The novel recombinant hirudin, r-RGD-hirudin, inhibits thrombin and platelet aggregation. Here, we reported over-expression of 15N-labeled r-RGD-hirudin by Pichia pastoris in minimal medium. After extensive optimization, the yield of active r-RGD-hirudin reached ~600 mg/L when the yeast cells were cultured in a fermenter. The purified 15N-labeled r-RGD-hirudin retained full biological activity and was uniformly labeled. Heteronuclear NMR of the 15N-labeled r-RGD-hirudin was performed for the first time, and all signals in the heteronuclear single quantum coherence (HSQC) spectrum were successfully assigned.
Keywords: 15N-Labeling, NMR, Pichia pastoris, r-RGD-Hirudin
Protein & Peptide Letters
Title: Overproduction of 15N-Labeled r-RGD-Hirudin in Pichia pastoris for NMR Studies
Volume: 17 Issue: 10
Author(s): Jue Wang, Yanling Zhang, Shiyun Li, Xingang Liu, Xiaomin Yan, Houyan Song, Min Yu, Linsen Dai and Wei Mo
Affiliation:
Keywords: 15N-Labeling, NMR, Pichia pastoris, r-RGD-Hirudin
Abstract: The novel recombinant hirudin, r-RGD-hirudin, inhibits thrombin and platelet aggregation. Here, we reported over-expression of 15N-labeled r-RGD-hirudin by Pichia pastoris in minimal medium. After extensive optimization, the yield of active r-RGD-hirudin reached ~600 mg/L when the yeast cells were cultured in a fermenter. The purified 15N-labeled r-RGD-hirudin retained full biological activity and was uniformly labeled. Heteronuclear NMR of the 15N-labeled r-RGD-hirudin was performed for the first time, and all signals in the heteronuclear single quantum coherence (HSQC) spectrum were successfully assigned.
Export Options
About this article
Cite this article as:
Wang Jue, Zhang Yanling, Li Shiyun, Liu Xingang, Yan Xiaomin, Song Houyan, Yu Min, Dai Linsen and Mo Wei, Overproduction of 15N-Labeled r-RGD-Hirudin in Pichia pastoris for NMR Studies, Protein & Peptide Letters 2010; 17 (10) . https://dx.doi.org/10.2174/092986610792231465
DOI https://dx.doi.org/10.2174/092986610792231465 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
Current Cardiology Reviews Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets Multiple Defects in Energy Metabolism in Alzheimers Disease
Current Drug Targets Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety Standard Terminologies for Photoplethysmogram Signals
Current Cardiology Reviews Actuation System Design for a Morphing Wing Trailing Edge
Recent Patents on Mechanical Engineering Is there U-turn from Insulin Back to Pills in Diabetes?
Current Vascular Pharmacology Recent Update on the Alzheimer's Disease Progression, Diagnosis and Treatment Approaches
Current Drug Targets Neuroprotection and Behavior Regulation by Adrenomedullin and PAMP as Shown by Conditional Knockout Models
Current Hypertension Reviews A Non-Steroidal Anti-Inflammatory Agent Provides Significant Protection During Focal Ischemic Stroke with Decreased Expression of Matrix Metalloproteinases
Current Neurovascular Research Sedation in PACU: Indications, Monitoring, Complications
Current Drug Targets Statins and Ischaemia Reperfusion Injury: A Molecular Biological Review
Current Vascular Pharmacology Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?)
Current Vascular Pharmacology Calcifediol – More than the Stepchild of CKD-MBD Therapy?
Current Vascular Pharmacology The Phosphodiesterase III Inhibitor Cilostazol Ameliorates Ethanolinduced Endothelial Dysfunction
Current Neurovascular Research A Review of Dietary Influences on Cardiovascular Health: Part 2: Dietary Patterns
Cardiovascular & Hematological Disorders-Drug Targets Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy
Current Drug Targets Impact of Metabolic Surgery on Type-2 Diabetes Remission
Current Diabetes Reviews Mechanisms, Prevention and Treatment of Distal Embolization
Current Pharmaceutical Design Exploiting Endogenous Cellular Process to Generate Quinone Methides In Vivo
Current Organic Chemistry